Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

John Paul Carter, Aroon D. Hingorani, John Wilkins, Amand Floriaan Schmidt

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbere319629
Pages (from-to)14-15
Number of pages2
JournalHeart (British Cardiac Society)
Volume108
Issue number1
DOIs
Publication statusPublished - 1 Jan 2022
Externally publishedYes

Keywords

  • Antibodies, Monoclonal/therapeutic use
  • Anticholesteremic Agents
  • Cardiovascular Diseases/prevention & control
  • Humans
  • Proprotein Convertase 9
  • Secondary Prevention

Cite this